TAK
Takeda Pharmaceutical Company Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · JP
$18.45
−1.39%Forward multiples
Based on analyst estimates
- P/E forward
- 38.76x
- P/E 2026E
- 45.84x
- P/E 2027E
- 28.75x
- P/E 2028E
- 23.54x
- P/S forward
- 1.95x
Trailing multiples
Trailing twelve months
- P/E TTM
- 49.95x
- PEG TTM
- 1.74x
- Price / book
- 1.21x
- Price / sales
- 1.97x
- Price / cash flow
- 9.63x
Enterprise value
- Enterprise value
- $87.2B
- EV / sales
- 2.92x
- EV / EBITDA
- 10.72x
- EV / EBIT
- 26.55x
- Market cap
- $58.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026